Nokea
The nurse is discussing the use of adsorbents such as bismuth subsalicylate with a patient who has diarrhea. The nurse will warn the patient about which possible adverse effects?
- A. Dark stools and blue gums
- B. Urinary hesitancy
- C. Drowsiness and dizziness
- D. Blurred vision and headache
Correct Answer: A
Rationale: Dark stools and blue gums are two of the possible adverse effects of bismuth subsalicylate. The other adverse effects listed may occur with the use of other antidiarrheal drugs.
You may also like to solve these questions
A patient asks the nurse about the difference between diphenoxylate with atropine and the over-the-counter drug loperamide (Imodium). Which response by the nurse is correct?
- A. Lomotil acts faster than Imodium.
- B. Imodium does not cause physical dependence.
- C. Lomotil is available in suppository form.
- D. Imodium is a natural antidiarrheal drug.
Correct Answer: B
Rationale: Although the drug exhibits many characteristics of the opiate class, physical dependence on loperamide has not been reported. All antidiarrheal drugs are orally administered. The other options are incorrect.
A patient is taking linaclotide to treat irritable bowel syndrome (IBS). The nurse will monitor this patient for which adverse effect?
- A. Chest pain
- B. Chronic constipation
- C. Abdominal pain
- D. Elevated blood glucose levels
Correct Answer: C
Rationale: Common adverse effects of linaclotide (Linzess) are diarrhea, abdominal pain, and flatulence. Elevated blood glucose levels, chest pain, and chronic constipation are not adverse effects of linaclotide.
When administering mineral oil, the nurse recognizes that it can interfere with the absorption of which substance?
- A. Fat-soluble vitamins
- B. Water-soluble vitamins
- C. Minerals
- D. Electrolytes
Correct Answer: A
Rationale: Mineral oil can decrease the absorption of fat-soluble vitamins (A, D, E, and K). The other options are incorrect.
The nurse is preparing to administer methylnaltrexone. This drug is appropriate for which patient?
- A. A patient with diarrhea
- B. A terminally ill patient who has opioid-induced constipation
- C. A patient who is scheduled for a colonoscopy
- D. A patient who will be having colon surgery in the morning
Correct Answer: B
Rationale: Methylnaltrexone is approved only for terminally ill (hospice) patients who have opioid-induced constipation. The other options are incorrect.
A patient will be receiving docusate sodium, 120 mg/day PO, divided into 3 doses. Identify how many milligrams will this patient receive per dose.
Correct Answer: 40 mg
Rationale: 120 mg/day ?· 3 doses/day = 40 mg.